|
|
Blood, Vol. 110, Issue 6, 2166-2172, September 15, 2007
Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin
Blood Villagra et al.
110: 2166
Supplemental materials for Villagra et al, Vol 110, Issue 6, 2166-2172
Files in this Data Supplement:
- Table S1. All SCD patients: percentage of activated platelets off vs. on hydroxyurea (PDF, 12.3 KB) -
Values indicate medians and interquartile ranks; P value by Mann-Whitney test, n = 33. One GPIIb/IIIa data point is missing for GPIIb/IIIa group.
- Table S2. SCD Patients on hydroxyurea: PAH vs. no PAH (PDF, 12.4 KB) -
Values indicate medians and interquartile ranks; P value by Mann-Whitney test.
- Table S3. SCD Patients off hydroxyurea: PAH vs. no PAH (PDF, 12.4 KB) -
Values indicate medians and interquartile ranks; P value by Mann-Whitney test.
- Table S4. Correlations of TRV to platelet activation markers by hydroxyurea status (PDF, 14.2 KB) -
Values indicate Spearman correlation coefficients, with associated p values. One GPIIb/IIIa data point is missing for “All SCD” and “On Hydroxyurea” groups.
- Table S5. Correlation between GPIIb/IIIa activation and surface P-selectin, percentage activated, and mean florescence intensity (PDF, 14.1 KB) -
Values indicate Spearman correlation coefficients and associated P values, n = 33.
- Table S6. Mean fluorescent intensity: SCD without PAH vs. with PAH (PDF, 12.4 KB) -
Values indicate medians and interquartile ranks; P value by Mann-Whitney test.
- Table S7. Mean fluorescent intensity: SCD without hydroxyurea vs. with hydroxyurea (PDF, 12.3 KB) -
Values indicate medians and interquartile ranks; P value by Mann-Whitney test.
| |
